drugs compete with Proscar (finasteride) for benign prostatic hyperplasia
December 2002
You will eventually see drugs compete with Proscar (finasteride) for benign prostatic hyperplasia.
For example, Avodart (dutasteride) is under consideration by Health Canada. It's similar to Proscar, but it blocks both types of 5 alpha-reductase. Proscar selectively blocks only type 2.
By blocking both type 1 and type 2, Avodart appears to lower dihydrotestosterone levels more than Proscar.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive